A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Eli Lilly and Company's shares rose during the quarter as Zepbound’s obesity launch continued to gain strong traction. Read ...

Patients with new-onset alopecia areata are at increased 10-year risk of developing several immune-mediated inflammatory diseases, according to a study.

During the fourth quarter of 2025, the Fund returned 13.10% (Institutional Shares), outperforming the Russell 3000 Index ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Supplements, surprising treatments, immunity-boosting vaccines and even exercises can help the immune system do its job ...

TULSA, OK - March 02, 2026 - PRESSADVANTAGE - RestoPros of Tulsa, a certified restoration company serving the greater ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Liver-related side effects have led some analysts to question fenebrutinib’s prospects, even though the drug has now cleared ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have ...

The microneedle patch about the size of a quarter samples key cells often missed in routine blood samples and biopsies.